BCM
Bridgeway Capital Management Portfolio holdings
AUM
$4.21B
1-Year Return
17.73%
This Quarter Return
+10.69%
1 Year Return
+17.73%
3 Year Return
+87.27%
5 Year Return
+258.36%
10 Year Return
+515.25%
AUM
$4.63B
AUM Growth
+$354M
(+8.3%)
Cap. Flow
+$37.6M
Cap. Flow
% of AUM
0.81%
Top 10 Holdings %
Top 10 Hldgs %
6.93%
Holding
1,360
New
97
Increased
499
Reduced
329
Closed
107
Top Buys
| 1 |
Phinia Inc
PHIN
|
+$19.7M |
| 2 |
TEGNA Inc
TGNA
|
+$18.1M |
| 3 |
Kohl's
KSS
|
+$15.6M |
| 4 |
Central Garden & Pet Class A
CENTA
|
+$13.7M |
| 5 |
Adient
ADNT
|
+$12M |
Top Sells
| 1 |
Merchants Bancorp
MBIN
|
+$10.7M |
| 2 |
Abercrombie & Fitch
ANF
|
+$10.1M |
| 3 |
Applovin
APP
|
+$7.89M |
| 4 |
CleanSpark
CLSK
|
+$7.03M |
| 5 |
Sinclair Inc
SBGI
|
+$6.69M |
Sector Composition
| 1 | Financials | 27.27% |
| 2 | Consumer Discretionary | 14.01% |
| 3 | Industrials | 12.46% |
| 4 | Technology | 10.12% |
| 5 | Healthcare | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSVT
801
DELISTED
2seventy bio
TSVT
| $645K | 0.01% |
136,700
+25,000
| +22% | +$118K |
|
802
Omeros
OMER
$291M
| $640K | 0.01% |
161,300
| – | – |
|
803
Biogen
BIIB
$20.9B
| $640K | 0.01% |
3,300
+1,300
| +65% | +$252K |
|
804
scPharmaceuticals
SCPH
$301M
| $638K | 0.01% |
139,900
-49,100
| -26% | -$224K |
|
805
Etsy
ETSY
$5.73B
| $633K | 0.01% |
11,400
+5,700
| +100% | +$317K |
|
806
SCYNEXIS
SCYX
$43.6M
| $630K | 0.01% |
422,846
+50,092
| +13% | +$74.6K |
|
807
CareCloud
CCLD
$148M
| $628K | 0.01% |
237,804
-29,790
| -11% | -$78.6K |
|
808
InfuSystem Holdings
INFU
$206M
| $620K | 0.01% |
92,600
+45,000
| +95% | +$302K |
|
809
Innodata
INOD
$1.85B
| $620K | 0.01% |
36,955
-4,400
| -11% | -$73.8K |
|
810
Trevi Therapeutics
TRVI
$1.17B
| $620K | 0.01% |
185,481
| – | – |
|
811
BGSF Inc
BGSF
$71.8M
| $618K | 0.01% |
73,400
+32,800
| +81% | +$276K |
|
|
TECX
812
Tectonic Therapeutic, Inc. Common Stock
TECX
$324M
| $618K | 0.01% |
20,381
+600
| +3% | +$18.2K |
|
813
Amgen
AMGN
$150B
| $612K | 0.01% |
1,900
-4,400
| -70% | -$1.42M |
|
814
Cato Corp
CATO
$89.6M
| $609K | 0.01% |
122,004
+2,278
| +2% | +$11.4K |
|
815
M-tron Industries
MPTI
$142M
| $609K | 0.01% |
14,600
| – | – |
|
|
AFCG
816
AFC Gamma
AFCG
$102M
| $609K | 0.01% |
59,600
-138,050
| -70% | -$1.41M |
|
817
Vertex Pharmaceuticals
VRTX
$99.6B
| $605K | 0.01% |
1,300
| – | – |
|
818
Rhinebeck Bancorp
RBKB
$146M
| $604K | 0.01% |
65,314
-12,454
| -16% | -$115K |
|
819
NCS Multistage Holdings
NCSM
$131M
| $603K | 0.01% |
30,182
+938
| +3% | +$18.8K |
|
820
Gaia
GAIA
$146M
| $598K | 0.01% |
122,800
| – | – |
|
821
Acacia Research
ACTG
$304M
| $596K | 0.01% |
127,945
-109,251
| -46% | -$509K |
|
822
LendingClub
LC
$1.86B
| $589K | 0.01% |
51,557
-287,472
| -85% | -$3.29M |
|
823
Biomea Fusion
BMEA
$109M
| $589K | 0.01% |
+58,300
| New | +$589K |
|
824
Assertio
ASRT
$77.5M
| $588K | 0.01% |
498,601
+88,664
| +22% | +$105K |
|
825
Relmada Therapeutics
RLMD
$53.4M
| $587K | 0.01% |
181,077
| – | – |
|